Keros Therapeutics, Inc.

KROSNasdaq· Pharmaceutical Preparations

Price History

Revenue

$244.1M

▲ 6775.0% YoY

Net Income

$87.0M

▲ 146.4% YoY

EPS

$2.30

▲ 146.0% YoY

Cash

$287.4M

▼ 48.7% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.